2019 News

Vancouver BC / NEWSWIRE / December 16, 2019 /CNW/ - Agrios Global Holdings Ltd. (CSE: AGRO) (OTCQB: AGGHF) (FSE: ØSA - WKN-A2N62K) ("Agrios" or the "Company") is pleased to announce Agrios was chosen for inclusion in The Cannabis Business Times, (“CBT”) 2019 editors list of favorite stories.

In December of each year, CBT’s five editors chose one story for the annual “List of Favorites”.    When considering the articles published in 2019, Andrea Sparr-Jaswa, Science Editor at CBT chose the guest column published in the October 2019 issue entitled Sativa vs. Indica, written by Dr. Curt Livesay, Director of Agronomy Services at Agrios Global. In addition to the article, an informative webinar was co-hosted on October 8, 2019, by Ms. Sparr-Jaswa and Dr. Livesay on the topic of “Sativa vs Indica”, which CBT noted was one off the publishers most successful webinars to date.

Rounding out the 2019 list of favorites were; Vaping-Related Lung Illness chosen by Noelle Skodzinski Editorial Director, Going Public Series chosen by Michelle Simakis, Editor, The Science Void, chosen by Johnathan Katz, Managing Editor, and Diversity and Differentiate, chosen by Brian MacIver, Senior Editor. 

Ms. Sparr-Jaswa in summarizing her choice noted, “In this continuation of the conversation around the indica-sativa debate, Director of Agronomy Services at Agrios Global Holdings, Dr. Curtis Livesay, evidences recent research as he makes the case for moving past this conflicted classification system once and for all. Livesay's work was brought to life in a subsequent discussion between the author and CBT in one of the publication’s most successful  webinars to date.“  Dr. Livesay’s article can be found at;  

Dr. Livesay notes consumers and cannabis growers alike must understand the implications of characterizing the cultivars that are being sold into the legal market. Retailers must know how to position these products for a consumer and patient base that relies on cannabis businesses for education, guidance, accuracy and, consistency. If you have questions and wish to continue the discussion with Dr. Livesay please go to and submit your question for his consideration and response.   

“I would like to congratulate Curt on being chosen as one of CBT’s favorite submissions in 2019.  In receiving this designation Curt further confirms the strength and depth of knowledge our entire team possesses and utilizes on a daily basis in building a  strong and well-positioned company whose unique differentiator is enabling us to create long term value for our shareholders,” stated Chris Kennedy, President & CEO of Agrios.  

About Agrios Global Holdings Ltd.

Agrios Global Holdings is a data analytics-driven agriculture technology and services company advancing the latest innovations in indoor growing science. The Company owns, leases and manages properties and equipment for eco-sustainable agronomy and provides advisory services to support all aspects of aeroponic cultivation in the cannabis sector. Agrios is actively pursuing new opportunities to expand its portfolio of tenant growers and infrastructure assets in strategic licensed jurisdictions. Based in Vancouver, BC. Agrios is managed by a highly accomplished team of experienced industry and capital markets experts who are committed to the growth of the company.

For further information please contact:

Ute Koessler
T: 604-336-2444

This news release was prepared by management of Agrios, which takes full responsibility for its contents. The Canadian Securities Exchange ("CSE") has not reviewed and does not accept responsibility for the adequacy of this news release.  Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in Agrios' periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should," and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements related to corporate strategy and Agrios’ ability to execute such strategy, future developments regarding Agrios’ expansion into various markets including numerous states within the United States of America, and into Asia, expected costs of hemp fiber, intended development and sales of hemp products, market demand for hemp products, and the business and operations of Agrios as it relates to the Yunnan Province.

Although Agrios has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited or no operating history and are engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry and; regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. Because of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. Agrios disclaims any intention or obligation to update or revise such information, except as required by applicable law, and Agrios does not assume any liability for disclosure relating to any other company mentioned herein.


Subscribe for email updates